Private Banking|Professional Solutions|Investment Management|Investment Banking|About us
Van Lanschot Kempen Logo
  • Solutions
  • Sectors
  • Careers
Jul 2015
Sole Global Coordinator & Joint Bookrunner
€ 32.7 million
Initial Public Offering

Kiadis Pharma

Kiadis Pharma is a clinical stage biopharmaceutical company focused on cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders

  • Kiadis Pharma floated on Euronext Amsterdam and Euronext Brussels
  • Proceeds of the IPO will be used to advance the clinical development of the lead products
  • Kempen & Co acted as Sole Global Coordinator and Joint Bookrunner in the transaction

Fully focused on your future

Private Banking

  • Offices
  • Entrepreneurs
  • Healthcare
  • Executives
  • Business professionals
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland

Professional Solutions

Investment Management

Investment Banking

© Van Lanschot Kempen NV 2023
About us
Security and fraud awareness
Privacy & cookies